↓ Skip to main content

ACTIVATE-2: A Double-Blind Randomized Trial of BCG Vaccination Against COVID-19 in Individuals at Risk

Overview of attention for article published in Frontiers in immunology, July 2022
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
26 news outlets
twitter
384 X users

Citations

dimensions_citation
58 Dimensions

Readers on

mendeley
81 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
ACTIVATE-2: A Double-Blind Randomized Trial of BCG Vaccination Against COVID-19 in Individuals at Risk
Published in
Frontiers in immunology, July 2022
DOI 10.3389/fimmu.2022.873067
Pubmed ID
Authors

Maria Tsilika, Esther Taks, Konstantinos Dolianitis, Antigone Kotsaki, Konstantinos Leventogiannis, Christina Damoulari, Maria Kostoula, Maria Paneta, Georgios Adamis, Ilias Papanikolaou, Kimon Stamatelopoulos, Amalia Bolanou, Konstantinos Katsaros, Christina Delavinia, Ioannis Perdios, Aggeliki Pandi, Konstantinos Tsiakos, Nektarios Proios, Emmanouela Kalogianni, Ioannis Delis, Efstathios Skliros, Karolina Akinosoglou, Aggeliki Perdikouli, Garyfallia Poulakou, Haralampos Milionis, Eva Athanassopoulou, Eleftheria Kalpaki, Leda Efstratiou, Varvara Perraki, Antonios Papadopoulos, Mihai G. Netea, Evangelos J. Giamarellos-Bourboulis

X Demographics

X Demographics

The data shown below were collected from the profiles of 384 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 81 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 81 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 10 12%
Student > Ph. D. Student 7 9%
Student > Bachelor 7 9%
Researcher 6 7%
Other 4 5%
Other 10 12%
Unknown 37 46%
Readers by discipline Count As %
Medicine and Dentistry 14 17%
Biochemistry, Genetics and Molecular Biology 4 5%
Agricultural and Biological Sciences 4 5%
Immunology and Microbiology 4 5%
Nursing and Health Professions 4 5%
Other 12 15%
Unknown 39 48%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 456. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 November 2023.
All research outputs
#61,955
of 25,887,951 outputs
Outputs from Frontiers in immunology
#57
of 32,529 outputs
Outputs of similar age
#1,926
of 440,906 outputs
Outputs of similar age from Frontiers in immunology
#5
of 2,027 outputs
Altmetric has tracked 25,887,951 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,529 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 440,906 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 2,027 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.